Sample Set Annotation Tool: Systems biology of vaccination for seasonal influenza in humans. GSE29619 (GPL570)

Study Design
Assay
Sample Info
Files
Info
Samples
Group Sets
Analysis

Purpose

This SuperSeries is composed of the following SubSeries;

- GSE29614 Time Course of Young Adults Vaccinated with Influenza TIV Vaccine during 2007/08 Flu Season

- GSE29615 Time Course of Young Adults Vaccinated with Influenza LAIV Vaccine during 2008/09 Flu Season

- GSE29617 Time Course of Young Adults Vaccinated with Influenza TIV Vaccine during 2008/09 Flu Season

Hypothesis

Experimental Design

Refer to individual Series

Experimental Variables

Controls

Methods

Additional Information

Expected Samples:

27 Samples Loaded: 27

Species

Human (Homo sapiens)

Sample Source

PBMC

Disease

Influenza vaccine

Treatment Protocol

Growth Protocol

Extraction Protocol

Storage Conditions

Sample Set Spreadsheet

Please log in in order to upload files.

Samples Preview

Sample ID	!Sample Title	group	Cell type	vaccine	Subject id
GSM733816	2007 TIV subject ID 12 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12
GSM733817	2007 TIV subject ID 12 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12
GSM733818	2007 TIV subject ID 12 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12
GSM733819	2007 TIV subject ID 16 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16
GSM733820	2007 TIV subject ID 16 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16

Please log in in order to upload files.

File
sampleset4000073_sampleannotations_Group.csv Sample Set Spreadsheet
sampleset4000073_sampleannotations_Group.csv Sample Set Spreadsheet

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID	!Sample Title	Group	Cell type	Vaccine	Subject id	Time point	Hai titer (day 0) - a/ solomon islands/3/2006 (h1n1)	Hai titer (day 0) - a/wisconsin/67/2005 (h3n2)	Hai titer (day 0) - b/malaysia/2506/2004	Hai titer (day 28) - a/ solomon islands/3/2006 (h1n1)	Hai titer (day 28) - a/wisconsin/67/2005 (h3n2)	Hai titer (day 28) - b/malaysia/2506/2004
GSM733816	2007 TIV subject ID 12 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12	D0	40	80	10	640	160	10
GSM733817	2007 TIV subject ID 12 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12	D3	40	80	10	640	160	10
GSM733818	2007 TIV subject ID 12 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	12	D7	40	80	10	640	160	10
GSM733819	2007 TIV subject ID 16 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D0	40	5	10	640	160	20
GSM733820	2007 TIV subject ID 16 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D3	40	5	10	640	160	20
GSM733821	2007 TIV subject ID 16 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	16	D7	40	5	10	640	160	20
GSM733822	2007 TIV subject ID 18 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	18	D0	160	80	5	160	80	5
GSM733823	2007 TIV subject ID 18 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	18	D3	160	80	5	160	80	5
GSM733824	2007 TIV subject ID 18 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	18	D7	160	80	5	160	80	5
GSM733825	2007 TIV subject ID 21 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	21	D0	160	5	5	640	80	5
GSM733826	2007 TIV subject ID 21 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	21	D3	160	5	5	640	80	5
GSM733827	2007 TIV subject ID 21 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	21	D7	160	5	5	640	80	5
GSM733828	2007 TIV subject ID 23 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	23	D0	5	5	5	2560	20	5
GSM733829	2007 TIV subject ID 23 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	23	D3	5	5	5	2560	20	5
GSM733830	2007 TIV subject ID 23 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	23	D7	5	5	5	2560	20	5
GSM733831	2007 TIV subject ID 29 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D0	40	5	5	80	160	40
GSM733832	2007 TIV subject ID 29 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D3	40	5	5	80	160	40
GSM733833	2007 TIV subject ID 29 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	29	D7	40	5	5	80	160	40
GSM733834	2007 TIV subject ID 32 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D0	40	20	5	2560	160	80
GSM733835	2007 TIV subject ID 32 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D3	40	20	5	2560	160	80
GSM733836	2007 TIV subject ID 32 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	32	D7	40	20	5	2560	160	80
GSM733837	2007 TIV subject ID 35 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D0	5	40	5	40	640	5
GSM733838	2007 TIV subject ID 35 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D3	5	40	5	40	640	5
GSM733839	2007 TIV subject ID 35 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	35	D7	5	40	5	40	640	5
GSM733840	2007 TIV subject ID 39 at D0 post-vaccination	TIV D0	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D0	80	2560	80	160	2560	80
GSM733841	2007 TIV subject ID 39 at D3 post-vaccination	TIV D3	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D3	80	2560	80	160	2560	80
GSM733842	2007 TIV subject ID 39 at D7 post-vaccination	TIV D7	PBMC	TIV (Fluarix, GlaxoSmithKline Biologicals)	39	D7	80	2560	80	160	2560	80

Group Sets View in Gene Expression Browser

Name
All Samples	Default	View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set
All Samples

SIDRA